Press Releases Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Delayed Nasdaq Other stock markets 02:30:00 23/02/2019 am IST			5-day change	1st Jan Change
6.47 ^USD	-0.31%		-.--%	-.--%

18/01	Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.	CI
2023	Scientists see risk of lost opportunity for long COVID research in China	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sinovac - WHO releases 2024-2025 Northern Hemisphere influenza vaccine component recommendations, changes to H3N2 virus	26/02	AQ
Sinovac Amends Shareholder Rights Plan	21/02	BU
Beijing Sinovac Zhongwei Biotechnology Co., Ltd.'s 2024 information disclosure on environmental pollution prevention and control by hazardous wastes	26/01	AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	18/01	BU
Alternative Liquidity Capital Announces Offer to Purchase Common Shares in Sinovac Biotech Ltd.	11/01	AQ
Sinovac - Study shows, Children aged 3-8 years old receive 2 doses of influenza vaccine for better protection	30/23/30	AQ
Sinovac Biotech Ltd - A delegation from the Indonesian Ministry of Health visited Sinovac	26/23/26	AQ
Sinovac - Sharing and co-building China Sinovac has supplied more than 1.2 billion doses of vaccines to 62 'Belt and Road' countries	23/23/23	AQ
Sinovac Biotech : Clinical trials will advance treatment of COVID-19 infection - Form 6-K	11/23/11	PU
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection	11/23/11	BU
The first study on the protective effect of influenza vaccine for Chinese military personnel shows that Sinovac influenza vaccine has good immunogenicity and safety among military personnel	06/23/06	AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	05/23/05	BU
Sinovac Holdings Biotechnology Co., Ltd. - Announcement on Industrial and Commercial Change of Beijing Kexing Biological Products Co., Ltd.	30/23/30	AQ
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer	29/23/29	BU
Sinovac Announces Change of Legal Representative of Sinovac Beijing	28/23/28	BU
Sinovac Biotech Ltd. - The second information disclosure of the environmental impact assessment of the Vaccine Quality Research Center project	23/23/23	AQ
Sinovac Biotech Ltd. - The first information announcement of the environmental impact assessment of the vaccine production workshop and its supporting facilities phase II construction project	16/23/16	AQ
SINOVAC Reports Unaudited First Half of 2023 Financial Results	15/23/15	BU
Sinovac Biotech Ltd. - Hepatitis A antibody is at a low level, and the prevention and control of adult hepatitis A has a long way to go	27/23/27	AQ
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines	10/23/10	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Press Releases

Filters